Target intelligence / Profile preview

Delta sleep-inducing peptide, immunoreactor pseudogene

Molecular classification
Other (Pseudogene, Leucine zipper protein family, TSC22 domain protein family)
01

Overview

The "Delta sleep-inducing peptide, immunoreactor pseudogene" (gene symbol ENSG00000236413, also known as LOC107985643) is listed in genomic databases as a **pseudogene** associated with the TSC22 domain protein family, containing sequence resemblance to leucine zipper-containing proteins and transcriptional regulators such as TSC22 domain family protein 3[1]. This pseudogene shares significant sequence similarity with the murine TSC-22 and Drosophila shs gene products and is sometimes referred to by aliases suggesting an association with the originally described **delta sleep-inducing peptide (DSIP)** and related immunoreactive proteins. Unlike the biologically active DSIP peptide or its putative protein immunoreactors, this entry represents a **pseudogene**—a non-functional gene copy—and is not known to encode a protein or act as a therapeutic target, receptor, enzyme, or transporter. **No direct biological or therapeutic function has been established for this pseudogene, and it is not a direct target for drugs or research into sleep regulation or related disorders**[1].

Other names
Delta sleep-inducing peptide immunoreactorDSIP immunoreactive peptideTSC22 domain family protein 3 isoform 3TSC-22-related proteinTSC-22-like proteinLOC107985643
02

Biological functions

Null (No direct biological function; pseudogene)
03

Disease associations

Null (No established disease role; pseudogene)

Beyond the preview

Go deeper on Delta sleep-inducing peptide, immunoreactor pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delta sleep-inducing peptide, immunoreactor pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call